Btk Ligand

TAE648 is a target protein ligand of PROTAC SK-3-91 (HY-137341) (Ligand for Target Protein for PROTAC). TAE648 can be used for synthesis PROTAC. TAE648 decreases monolayer-cultured SKOV3ip1 cell viability.

N-Deshydroxyethyl Dasatinib (N-Deshydroxyethyl BMS-354825) is a metabolite of Dasatinib, Dasatinib is a multi-kinase inhibitor that potently inhibits Bcr-Abl, Src family and platelet-derived growth factor receptor kinases. N-Deshydroxyethyl Dasatinib can be used in cancer and immune disease research.

BTK ligand 12 is a PROTAC target protein ligand (Ligands for Target Protein for PROTACs). BTK ligand 12 can serve as an active control for the target protein ligand of NRX-0492 (HY-153357).

BTK ligand-20 (compound 1) is a BTK ligand. BTK ligand-20 serves as a target protein ligand for the synthesis of PROTAC BTK Degrader-15 (HY-182910). BTK ligand-20 is applicable to cancer research.

CRBN ligand-185 is a CRBN ligand. CRBN ligand-185 can be used as a target protein ligand for the synthesis of PROTACs targeting CRBN (Ligands for Target Protein for PROTAC), such as NX-5948 (HY-153321).

BTK ligand 15 is the target protein ligand of PROTAC BTK Degrader-13 (HY-168963). PROTAC BTK Degrader-13 can selectively degrade BTK.

BTK/IKZF1/3 ligand 1 is a BTK/IKZF1/3 PROTAC ligand. BTK/IKZF1/3 ligand 1 can be conjugated with E3 ligase Ligand (HY-41547) and linker to synthesize PROTAC BTK/IKZF1/3 Degrader-1 (HY-179077). PROTAC BTK/IKZF1/3 Degrader-1 can be used for cancer research.

BTK ligand 16 is a BTK ligand that can be used for synthesis of TQ-3959 (HY-175541).

BTK-IN-39 (0204) is a PROTAC target protein ligand that can be used to synthesize PROTAC BTK Degrader-11 (HY-159947).

BTK ligand-17 (The Target Protein Ligand Moiety of Catadegbrutinib) is a BTK ligand. BTK can be used as Ligands for Target Protein for PROTAC to develop and design degradative agents for PROTAC BTKs, such as Catadegbrutinib (HY-160141). BTK ligand-17 can also be used in cancer research.

BTK ligand-18 is a BTK ligand, which can be used for the synthesis of PROTACs, such as PROTAC BTK Degrader-9 (HY-162280).

BTK ligand 11 is a PROTAC target protein ligand that can be used to synthesize BCPyr (HY-142621).

BTK ligand 3 is a BTK ligand that can be used for the synthesis of PROTACs, such as PROTAC BTK Degrader-5 (HY-155072).

BTK ligand-19 is a PROTAC ligand of BTK, which is used to synthesize the PROTAC-based BTK degrader PROTAC BTK degrader-14 (HY-181623). BTK ligand-19 regulates cell apoptosis, cell cycle progression and kinase signaling cascades. BTK ligand-19 is applied in cancer research.